<table-wrap xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="table1" position="float"><object-id pub-id-type="doi">10.7554/eLife.50509.010</object-id><label>Table 1.</label><caption><title>In vitro properties of DHFR mutant proteins <sup>a</sup></title></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top"/><th valign="top">Wild type</th><th>D27F</th><th>D27N</th><th>D27G</th><th>D27C</th></tr></thead><tbody><tr><td valign="top"><italic>k</italic><sub>cat</sub> (s<sup>&#8722;1</sup>)</td><td>13&#160;&#177;&#160;2</td><td>(5&#160;&#177;&#160;1)&#215;10<sup>&#8722;4</sup></td><td>(2.6&#160;&#177; 0.9) &#215; 10<sup>&#8722;2</sup></td><td>(1.8&#160;&#177;&#160;0.4)&#215;10<sup>&#8722;2</sup></td><td>3&#160;&#177;&#160;0.8</td></tr><tr><td valign="top"><italic>K</italic><sub>M</sub> (&#956;M)</td><td>0.8&#160;&#177;&#160;0.2</td><td>(1.2&#160;&#177;&#160;0.6)&#215;10<sup>2</sup></td><td>(4&#160;&#177;&#160;1)&#215;10<sup>1</sup></td><td>23&#160;&#177;&#160;7</td><td>(7&#160;&#177;&#160;2)&#215;10<sup>1</sup></td></tr><tr><td valign="top"><italic>k</italic><sub>cat</sub>/<italic>K</italic><sub>M</sub> (s<sup>&#8722;1</sup> &#956;M<sup>&#8722;1</sup>)</td><td>16&#160;&#177;&#160;1</td><td>(4&#160;&#177;&#160;1)&#215;10<sup>&#8722;6</sup></td><td>(7&#160;&#177;&#160;0.8)&#215;10<sup>&#8722;4</sup></td><td>(8&#160;&#177;&#160;2)&#215;10<sup>&#8722;4</sup></td><td>(4.2&#160;&#177;&#160;0.8)&#215;10<sup>&#8722;2</sup></td></tr><tr><td valign="top"><italic>k<sub>cat</sub>/K<sub>M</sub></italic> relative to wild type</td><td>-</td><td>2&#160;&#215;&#160;10<sup>&#8722;7</sup></td><td>4&#160;&#215;&#160;10<sup>&#8722;5</sup></td><td>3&#160;&#215;&#160;10<sup>&#8722;5</sup></td><td>2&#160;&#215;&#160;10<sup>&#8722;3</sup></td></tr><tr><td valign="top"><italic>K</italic><sub>i</sub> (nM)</td><td>1.0&#160;&#177;&#160;0.3</td><td>ND</td><td>ND</td><td>ND</td><td>(1.7&#160;&#177;&#160;0.7)&#215;10<sup>4</sup></td></tr><tr><td valign="top">&#916;<italic>T</italic><sub>m</sub> (<sup>0</sup>C)</td><td>-</td><td>+7.6&#160;&#177;&#160;0.1 <sup>b</sup></td><td>+1.1&#160;&#177;&#160;0.3</td><td>+1.2&#160;&#177;&#160;0.2</td><td>+0.6&#160;&#177;&#160;0.6</td></tr><tr><td valign="top">bis-ANS</td><td>1</td><td>1.1&#160;&#177;&#160;0.1</td><td>2.9&#160;&#177;&#160;0.3</td><td>1.7&#160;&#177;&#160;0.3</td><td>2.2&#160;&#177;&#160;0.5</td></tr></tbody></table><table-wrap-foot><fn><p><sup>a</sup> Kinetic properties for dihydrofolate reductase catalytic activity (<italic>k</italic><sub>cat</sub>&#160;=&#160;enzymatic turnover number, <italic>K</italic><sub>M</sub>&#160;=&#160;Michaelis Menten constant, <italic>k</italic><sub>cat</sub>/<italic>K</italic><sub>M</sub>&#160;=&#160;catalytic efficiency, <italic>K</italic><sub>i</sub>&#160;=&#160;inhibition constant for trimethoprim) and protein stability properties (&#916;T<sub>m</sub>&#160;=&#160;difference in melting temperature of folding with respect to wild type, bis-ANS&#160;=&#160;relative fluorescence from binding of bis-ANS to molten-globule intermediates with respect to wild type protein).</p></fn></table-wrap-foot></table-wrap>